Form 483

Adamson Analytical Laboratories, Inc. Form 483, 2017-02-10

FDA issued a Form 483 to Adamson Analytical Laboratories, Inc. on 2017-02-10 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Adamson Analytical Laboratories, Inc. · Corona, United States · Issued February 10, 2017

Overview

  • 4 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

10 Feb 2017
21 CFR 211.160(b)(4)

Calibration - at intervals, written program, remedial action

Cited by Carrie A Hughes, Joey V Quitania

10 Feb 2017
21 CFR 211.160(b)(4)

Instruments, apparatus, et. al. not meeting specs

Cited by Carrie A Hughes, Joey V Quitania

10 Feb 2017
21 CFR 211.194(d)

Laboratory equipment calibration records

Cited by Carrie A Hughes, Joey V Quitania

10 Feb 2017
21 CFR 211.22(c)

Approve or reject procedures or specs

Cited by Carrie A Hughes, Joey V Quitania

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations2x
21 CFR 211.194(d)Cited across public-safe Form 483 observations1x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere